Insider Buying: Tauriga Sciences CEO Buys 200,000 Shares of Stock (TAUG)
Tauriga Sciences (NASDAQ:TAUG) CEO Stella M. Sung purchased 200,000 shares of Tauriga Sciences stock in a transaction that occurred on Tuesday, June 24th. The shares were purchased at an average price of $0.02 per share, for a total transaction of $4,000.00. Following the purchase, the chief executive officer now directly owns 21,300,000 shares of the company’s stock, valued at approximately $426,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Tauriga Sciences (NASDAQ:TAUG) traded up 19.40% on Wednesday, hitting $0.024. 4,284,300 shares of the company’s stock traded hands. Tauriga Sciences has a 1-year low of $0.01 and a 1-year high of $0.11. The stock has a 50-day moving average of $0.02 and a 200-day moving average of $0.03. The company’s market cap is $12.6 million.
Tauriga Sciences, Inc, formerly Immunovative, Inc, develops the next generation immunotherapies to treat cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.